{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:55:23Z","timestamp":1790668523532,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:00:00Z","timestamp":1788825600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-026-01282-3","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T17:40:48Z","timestamp":1788889248000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Melittin-modified Paclitaxel Liposomes as a Synergistic Strategy for Anti-keloid Therapy"],"prefix":"10.1208","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-5732-2878","authenticated-orcid":false,"given":"Haozhong","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxiu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxue","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meijuan","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2089-1982","authenticated-orcid":false,"given":"Hongyu","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,8]]},"reference":[{"key":"1282_CR1","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/DSS.0000000000000819","volume":"43","author":"B Berman","year":"2017","unstructured":"Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and treatment. Dermatol Surg. 2017;43:S3-18. https:\/\/doi.org\/10.1097\/DSS.0000000000000819.","journal-title":"Dermatol Surg"},{"key":"1282_CR2","doi-asserted-by":"publisher","first-page":"606","DOI":"10.3390\/ijms18030606","volume":"18","author":"R Ogawa","year":"2017","unstructured":"Ogawa R. Keloid and hypertrophic scars are the result of chronic inflammation in the reticular dermis. Int J Mol Sci. 2017;18:606. https:\/\/doi.org\/10.3390\/ijms18030606.","journal-title":"Int J Mol Sci"},{"key":"1282_CR3","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.mehy.2008.01.032","volume":"71","author":"S Akaishi","year":"2008","unstructured":"Akaishi S, Ogawa R, Hyakusoku H. Keloid and hypertrophic scar: neurogenic inflammation hypotheses. Med Hypotheses. 2008;71:32\u20138. https:\/\/doi.org\/10.1016\/j.mehy.2008.01.032.","journal-title":"Med Hypotheses"},{"key":"1282_CR4","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fcell.2020.00360","volume":"8","author":"GC Limandjaja","year":"2020","unstructured":"Limandjaja GC, Niessen FB, Scheper RJ, Gibbs S. The keloid disorder: heterogeneity, histopathology, mechanisms and models. Front Cell Dev Biol. 2020;8:360. https:\/\/doi.org\/10.3389\/fcell.2020.00360.","journal-title":"Front Cell Dev Biol"},{"key":"1282_CR5","doi-asserted-by":"publisher","first-page":"117326","DOI":"10.1016\/j.lfs.2020.117326","volume":"254","author":"J Cui","year":"2020","unstructured":"Cui J, Jin S, Jin C, Jin Z. Syndecan-1 regulates extracellular matrix expression in keloid fibroblasts via TGF-\u03b21\/Smad and MAPK signaling pathways. Life Sci. 2020;254:117326. https:\/\/doi.org\/10.1016\/j.lfs.2020.117326.","journal-title":"Life Sci"},{"key":"1282_CR6","doi-asserted-by":"publisher","first-page":"116779","DOI":"10.1016\/j.lfs.2019.116779","volume":"234","author":"R Wang","year":"2019","unstructured":"Wang R, Bai Z, Wen X, Du H, Zhou L, Tang Z, et al. MiR-152-3p regulates cell proliferation, invasion and extracellular matrix expression through by targeting FOXF1 in keloid fibroblasts. Life Sci. 2019;234:116779. https:\/\/doi.org\/10.1016\/j.lfs.2019.116779.","journal-title":"Life Sci"},{"key":"1282_CR7","doi-asserted-by":"publisher","first-page":"5468","DOI":"10.1038\/s41598-021-84982-4","volume":"11","author":"MH Choi","year":"2021","unstructured":"Choi MH, Kim J, Ha JH, Park JU. A selective small-molecule inhibitor of c-Met suppresses keloid fibroblast growth in vitro and in a mouse model. Sci Rep. 2021;11:5468. https:\/\/doi.org\/10.1038\/s41598-021-84982-4.","journal-title":"Sci Rep"},{"key":"1282_CR8","doi-asserted-by":"publisher","first-page":"620","DOI":"10.5999\/aps.2014.41.6.620","volume":"41","author":"AT Perdanasari","year":"2014","unstructured":"Perdanasari AT, Lazzeri D, Su W, Xi W, Zheng Z, Ke L, et al. Recent developments in the use of intralesional injections keloid treatment. Arch Plast Surg. 2014;41:620\u20139. https:\/\/doi.org\/10.5999\/aps.2014.41.6.620.","journal-title":"Arch Plast Surg"},{"key":"1282_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.5999\/aps.2015.42.1.20","volume":"42","author":"J Choi","year":"2015","unstructured":"Choi J, Lee EH, Park SW, Chang H. Regulation of transforming growth factor \u03b21, platelet-derived growth factor, and basic fibroblast growth factor by silicone gel sheeting in early-stage scarring. Arch Plast Surg. 2015;42:20\u20137. https:\/\/doi.org\/10.5999\/aps.2015.42.1.20.","journal-title":"Arch Plast Surg"},{"key":"1282_CR10","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1097\/PRS.0000000000005257","volume":"143","author":"R LaRanger","year":"2019","unstructured":"LaRanger R, Karimpour-Fard A, Costa C, Mathes D, Wright WE, Chong T. Analysis of keloid response to 5-fluorouracil treatment and long-term prevention of keloid recurrence. Plast Reconstr Surg. 2019;143:490\u20134. https:\/\/doi.org\/10.1097\/PRS.0000000000005257.","journal-title":"Plast Reconstr Surg"},{"key":"1282_CR11","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.3390\/molecules21091137","volume":"21","author":"HJ An","year":"2016","unstructured":"An HJ, Kim JY, Kim WH, Han SM, Park KK. The protective effect of melittin on renal fibrosis in an animal model of unilateral ureteral obstruction. Molecules. 2016;21:1137. https:\/\/doi.org\/10.3390\/molecules21091137.","journal-title":"Molecules"},{"key":"1282_CR12","doi-asserted-by":"publisher","first-page":"100107","DOI":"10.1016\/j.crphar.2022.100107","volume":"3","author":"BF Moreira Castro","year":"2022","unstructured":"Moreira Castro BF, Nunes da Silva C, Barbosa Cordeiro LP, Pereira de Freitas Cenachi S, Vasconcelos-Santos DV, Machado RR, et al. Low-dose melittin is safe for intravitreal administration and ameliorates inflammation in an experimental model of uveitis. Curr Res Pharmacol Drug Discov. 2022;3:100107. https:\/\/doi.org\/10.1016\/j.crphar.2022.100107.","journal-title":"Curr Res Pharmacol Drug Discov"},{"key":"1282_CR13","doi-asserted-by":"publisher","first-page":"616","DOI":"10.3390\/molecules21050616","volume":"21","author":"G Lee","year":"2016","unstructured":"Lee G, Bae H. Anti-inflammatory applications of melittin, a major component of bee venom: detailed mechanism of action and adverse effects. Molecules. 2016;21:616. https:\/\/doi.org\/10.3390\/molecules21050616.","journal-title":"Molecules"},{"key":"1282_CR14","doi-asserted-by":"publisher","first-page":"17679","DOI":"10.1038\/s41598-017-17873-2","volume":"7","author":"WH Kim","year":"2017","unstructured":"Kim WH, An HJ, Kim JY, Gwon MG, Gu H, Jeon M, et al. Beneficial effects of melittin on ovalbumin-induced atopic dermatitis in mouse. Sci Rep. 2017;7:17679. https:\/\/doi.org\/10.1038\/s41598-017-17873-2.","journal-title":"Sci Rep"},{"key":"1282_CR15","doi-asserted-by":"publisher","first-page":"110864","DOI":"10.1016\/j.fct.2019.110864","volume":"134","author":"A Pascoal","year":"2019","unstructured":"Pascoal A, Estevinho MM, Choupina AB, Sousa-Pimenta M, Estevinho LM. An overview of the bioactive compounds, therapeutic properties and toxic effects of apitoxin. Food Chem Toxicol. 2019;134:110864. https:\/\/doi.org\/10.1016\/j.fct.2019.110864.","journal-title":"Food Chem Toxicol"},{"key":"1282_CR16","doi-asserted-by":"publisher","first-page":"4068","DOI":"10.1007\/s12010-021-03653-2","volume":"193","author":"HS Lee","year":"2021","unstructured":"Lee HS, Kim YS, Lee KS, Seo HS, Lee CY, Kim KK. Detoxification of bee venom increases its anti-inflammatory activity and decreases its cytotoxicity and allergenic activity. Appl Biochem Biotechnol. 2021;193:4068\u201382. https:\/\/doi.org\/10.1007\/s12010-021-03653-2.","journal-title":"Appl Biochem Biotechnol"},{"key":"1282_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.6114\/jkood.2015.28.3.101","volume":"28","author":"HY Kim","year":"2015","unstructured":"Kim HY, Hong SH, Park IH, Heo ES, Noh HM, Shin SH. Clinical study of twenty-seven case of treating acne scar using microneedle therapy and subcision combined with beevenom pharmacopuncture therapy. J Korean Med Ophthalmol Otolaryngol Dermatol. 2015;28:101\u201313. https:\/\/doi.org\/10.6114\/jkood.2015.28.3.101.","journal-title":"J Korean Med Ophthalmol Otolaryngol Dermatol"},{"key":"1282_CR18","doi-asserted-by":"publisher","first-page":"12732","DOI":"10.1021\/ja3042004","volume":"134","author":"AJ Krauson","year":"2012","unstructured":"Krauson AJ, He J, Wimley WC. Gain-of-function analogues of the pore-forming peptide melittin selected by orthogonal high-throughput screening. J Am Chem Soc. 2012;134:12732\u201341. https:\/\/doi.org\/10.1021\/ja3042004.","journal-title":"J Am Chem Soc"},{"key":"1282_CR19","doi-asserted-by":"publisher","first-page":"14243","DOI":"10.1073\/pnas.1307010110","volume":"110","author":"MT Lee","year":"2013","unstructured":"Lee MT, Sun TL, Hung WC, Huang HW. Process of inducing pores in membranes by melittin. Proc Natl Acad Sci U S A. 2013;110:14243\u20138. https:\/\/doi.org\/10.1073\/pnas.1307010110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1282_CR20","doi-asserted-by":"publisher","first-page":"8450","DOI":"10.1021\/acs.jpcb.1c02499","volume":"125","author":"S Pal","year":"2021","unstructured":"Pal S, Chakraborty H, Chattopadhyay A. Lipid headgroup charge controls melittin oligomerization in membranes: implications in membrane lysis. J Phys Chem B. 2021;125:8450\u20139. https:\/\/doi.org\/10.1021\/acs.jpcb.1c02499.","journal-title":"J Phys Chem B"},{"key":"1282_CR21","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1016\/j.bbamem.2014.04.012","volume":"1838","author":"CH Chen","year":"2014","unstructured":"Chen CH, Wiedman G, Khan A, Ulmschneider MB. Absorption and folding of melittin onto lipid bilayer membranes via unbiased atomic detail microsecond molecular dynamics simulation. Biochim Biophys Acta Biomembr. 2014;1838:2243\u20139. https:\/\/doi.org\/10.1016\/j.bbamem.2014.04.012.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"1282_CR22","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.neuropharm.2013.08.016","volume":"76","author":"E Gornstein","year":"2014","unstructured":"Gornstein E, Schwarz TL. The paradox of paclitaxel neurotoxicity: mechanisms and unanswered questions. Neuropharmacology. 2014;76:175\u201383. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.08.016.","journal-title":"Neuropharmacology"},{"key":"1282_CR23","doi-asserted-by":"publisher","first-page":"e22745","DOI":"10.1002\/jbt.22745","volume":"35","author":"MH Sharawy","year":"2021","unstructured":"Sharawy MH, El-Awady MS, Makled MN. Protective effects of paclitaxel on thioacetamide-induced liver fibrosis in a rat model. J Biochem Mol Toxicol. 2021;35:e22745. https:\/\/doi.org\/10.1002\/jbt.22745.","journal-title":"J Biochem Mol Toxicol"},{"key":"1282_CR24","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.lfs.2018.09.037","volume":"211","author":"MH Sharawy","year":"2018","unstructured":"Sharawy MH, Abdel-Rahman N, Megahed N, El-Awady MS. Paclitaxel alleviates liver fibrosis induced by bile duct ligation in rats: role of TGF-\u03b21, IL-10 and c-myc. Life Sci. 2018;211:245\u201351. https:\/\/doi.org\/10.1016\/j.lfs.2018.09.037.","journal-title":"Life Sci"},{"key":"1282_CR25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1590\/1806-9282.20210777","volume":"68","author":"J Lu","year":"2022","unstructured":"Lu J, Yu L, Shi J. Low-dose paclitaxel modulates the cross talk between the JNK and Smad signaling in primary biliary fibroblasts. Rev Assoc Med Bras. 2022;68:159\u201364. https:\/\/doi.org\/10.1590\/1806-9282.20210777.","journal-title":"Rev Assoc Med Bras"},{"key":"1282_CR26","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/j.biopha.2017.11.003","volume":"97","author":"Q Yang","year":"2018","unstructured":"Yang Q, Zhang D, Li Y, Li Y, Li Y. Paclitaxel alleviated liver injury of septic mice by alleviating inflammatory response via microRNA-27a\/TAB3\/NF-\u03baB signaling pathway. Biomed Pharmacother. 2018;97:1424\u201333. https:\/\/doi.org\/10.1016\/j.biopha.2017.11.003.","journal-title":"Biomed Pharmacother"},{"key":"1282_CR27","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.2147\/DDDT.S222296","volume":"13","author":"YM Wang","year":"2019","unstructured":"Wang YM, Ji R, Chen WW, Huang SW, Zheng YJ, Yang ZT, et al. Paclitaxel alleviated sepsis-induced acute lung injury by activating MUC1 and suppressing TLR-4\/NF-\u03baB pathway. Drug Des Devel Ther. 2019;13:3391\u2013404. https:\/\/doi.org\/10.2147\/DDDT.S222296.","journal-title":"Drug Des Devel Ther"},{"key":"1282_CR28","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.7150\/thno.30716","volume":"9","author":"P Wang","year":"2019","unstructured":"Wang P, Wang H, Huang Q, Peng C, Yao L, Chen H, et al. Exosomes from M1-polarized macrophages enhance paclitaxel antitumor activity by activating macrophages-mediated inflammation. Theranostics. 2019;9:1714\u201327. https:\/\/doi.org\/10.7150\/thno.30716.","journal-title":"Theranostics"},{"key":"1282_CR29","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.2147\/IJN.S195375","volume":"14","author":"M Wang","year":"2019","unstructured":"Wang M, Chen L, Huang W, Jin M, Wang Q, Gao Z, et al. Improving the anti-keloid outcomes through liposomes loading paclitaxel-cholesterol complexes. Int J Nanomedicine. 2019;14:1385\u2013400. https:\/\/doi.org\/10.2147\/IJN.S195375.","journal-title":"Int J Nanomedicine"},{"key":"1282_CR30","doi-asserted-by":"publisher","first-page":"183955","DOI":"10.1016\/j.bbamem.2022.183955","volume":"1864","author":"Y Miyazaki","year":"2022","unstructured":"Miyazaki Y, Shinoda W. Cooperative antimicrobial action of melittin on lipid membranes: a coarse-grained molecular dynamics study. Biochim Biophys Acta Biomembr. 2022;1864:183955. https:\/\/doi.org\/10.1016\/j.bbamem.2022.183955.","journal-title":"Biochim Biophys Acta Biomembr"},{"key":"1282_CR31","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jconrel.2016.03.012","volume":"229","author":"F Ravar","year":"2016","unstructured":"Ravar F, Saadat E, Gholami M, Dehghankelishadi P, Mahdavi M, Azami S, et al. Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation. J Control Release. 2016;229:10\u201322. https:\/\/doi.org\/10.1016\/j.jconrel.2016.03.012.","journal-title":"J Control Release"},{"key":"1282_CR32","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.addr.2004.06.002","volume":"57","author":"VP Torchilin","year":"2005","unstructured":"Torchilin VP. Fluorescence microscopy to follow the targeting of liposomes and micelles to cells and their intracellular fate. Adv Drug Deliv Rev. 2005;57:95\u2013109. https:\/\/doi.org\/10.1016\/j.addr.2004.06.002.","journal-title":"Adv Drug Deliv Rev"},{"issue":"2","key":"1282_CR33","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3831\/KPI.2006.9.2.105","volume":"9","author":"YC Choi","year":"2006","unstructured":"Choi YC, Kwon KR, Choi SH. Purification of peptide components including melittin from bee venom using gel filtration chromatography and propionic acid\/urea polyacrylamide gel electrophoresis. J Pharmacopuncture. 2006;9(2):105\u201311.","journal-title":"J Pharmacopuncture"},{"key":"1282_CR34","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/S0006-3495(01)75802-X","volume":"81","author":"L Yang","year":"2001","unstructured":"Yang L, Harroun TA, Weiss TM, Ding L, Huang HW. Barrel-stave model or toroidal model? A case study on melittin pores. Biophys J. 2001;81:1475\u201385. https:\/\/doi.org\/10.1016\/S0006-3495(01)75802-X.","journal-title":"Biophys J"},{"issue":"1","key":"1282_CR35","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3390\/biom12010118","volume":"12","author":"A Wang","year":"2022","unstructured":"Wang A, Zheng Y, Zhu W, Yang L, Yang Y, Peng J. Melittin-based nano-delivery systems for cancer therapy. Biomolecules. 2022;12(1):118. https:\/\/doi.org\/10.3390\/biom12010118.","journal-title":"Biomolecules"},{"issue":"9","key":"1282_CR36","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1172\/JCI38842","volume":"119","author":"NR Soman","year":"2009","unstructured":"Soman NR, Baldwin SL, Hu G, Marsh JN, Lanza GM, Heuser JE, et al. Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth. J Clin Invest. 2009;119(9):2830\u201342. https:\/\/doi.org\/10.1172\/JCI38842.","journal-title":"J Clin Invest"},{"issue":"8","key":"1282_CR37","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.3390\/pharmaceutics13081235","volume":"13","author":"Y Li","year":"2021","unstructured":"Li Y, Ruan S, Wang Z, Feng N, Zhang Y. Hyaluronic acid coating reduces the leakage of melittin encapsulated in liposomes and increases targeted delivery to melanoma cells. Pharmaceutics. 2021;13(8):1235. https:\/\/doi.org\/10.3390\/pharmaceutics13081235.","journal-title":"Pharmaceutics"},{"issue":"7","key":"1282_CR38","doi-asserted-by":"publisher","first-page":"5791","DOI":"10.1021\/nn400683s","volume":"7","author":"C Huang","year":"2013","unstructured":"Huang C, Jin H, Qian Y, Qi S, Luo H, Luo Q, et al. Hybrid melittin cytolytic peptide-driven ultrasmall lipid nanoparticles block melanoma growth in vivo. ACS Nano. 2013;7(7):5791\u2013800. https:\/\/doi.org\/10.1021\/nn400683s.","journal-title":"ACS Nano"},{"key":"1282_CR39","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/s41467-020-14906-9","volume":"11","author":"X Yu","year":"2020","unstructured":"Yu X, Dai Y, Zhao Y, Qi S, Liu L, Lu L, et al. Melittin-lipid nanoparticles target to lymph nodes and elicit a systemic anti-tumor immune response. Nat Commun. 2020;11:1110. https:\/\/doi.org\/10.1038\/s41467-020-14906-9.","journal-title":"Nat Commun"},{"issue":"47","key":"1282_CR40","doi-asserted-by":"publisher","first-page":"55902","DOI":"10.1021\/acsami.1c17618","volume":"13","author":"R Ye","year":"2021","unstructured":"Ye R, Zheng Y, Chen Y, Wei X, Shi S, Chen Y, et al. Stable loading and delivery of melittin with lipid-coated polymeric nanoparticles for effective tumor therapy with negligible systemic toxicity. ACS Appl Mater Interfaces. 2021;13(47):55902\u201312. https:\/\/doi.org\/10.1021\/acsami.1c17618.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"27","key":"1282_CR41","doi-asserted-by":"publisher","first-page":"13069","DOI":"10.1039\/C9NR01820D","volume":"11","author":"H Wang","year":"2019","unstructured":"Wang H, Wang S, Wang R, Wang X, Jiang K, Xie C, et al. Co-delivery of paclitaxel and melittin by glycopeptide-modified lipodisks for synergistic anti-glioma therapy. Nanoscale. 2019;11(27):13069\u201377. https:\/\/doi.org\/10.1039\/C9NR01820D.","journal-title":"Nanoscale"},{"issue":"1","key":"1282_CR42","first-page":"45","volume":"62","author":"I Rivolta","year":"2011","unstructured":"Rivolta I, Panariti A, Lettiero B, Sesana S, Gasco P, Gasco MR, et al. Cellular uptake of coumarin-6 as a model drug loaded in solid lipid nanoparticles. J Physiol Pharmacol. 2011;62(1):45\u201353.","journal-title":"J Physiol Pharmacol"},{"key":"1282_CR43","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.2147\/TCRM.S82961","volume":"11","author":"LP Huang","year":"2015","unstructured":"Huang LP, Wang GQ, Jia ZS, Chen JW, Wang G, Wang XL. Paclitaxel reduces formation of hypertrophic scars in the rabbit ear model. Ther Clin Risk Manag. 2015;11:1089\u201395. https:\/\/doi.org\/10.2147\/TCRM.S82961.","journal-title":"Ther Clin Risk Manag"},{"key":"1282_CR44","doi-asserted-by":"publisher","unstructured":"Fetterly GJ, Straubinger RM. Pharmacokinetics of paclitaxel-containing liposomes in rats. AAPS PharmSci. 2003;5(4). https:\/\/doi.org\/10.1208\/ps050432.","DOI":"10.1208\/ps050432"},{"issue":"5","key":"1282_CR45","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3892\/ijo.12.5.1035","volume":"12","author":"A Cabanes","year":"1998","unstructured":"Cabanes A, Briggs KE, Gokhale PC, Treat JA, Rahman A. Comparative in vivo studies with paclitaxel and liposome-encapsulated paclitaxel. Int J Oncol. 1998;12(5):1035\u201340. https:\/\/doi.org\/10.3892\/ijo.12.5.1035.","journal-title":"Int J Oncol"},{"issue":"5","key":"1282_CR46","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1142\/S0192415X14500712","volume":"42","author":"SH Park","year":"2014","unstructured":"Park SH, Cho HJ, Jeong YJ, Shin JM, Kang JH, Park KK, et al. Melittin inhibits TGF-\u03b2-induced pro-fibrotic gene expression through the suppression of the TGF\u03b2RII-Smad, ERK1\/2 and JNK-mediated signaling pathway. Am J Chin Med. 2014;42(5):1139\u201352. https:\/\/doi.org\/10.1142\/S0192415X14500712.","journal-title":"Am J Chin Med"},{"issue":"3","key":"1282_CR47","doi-asserted-by":"publisher","first-page":"69","DOI":"10.3390\/cosmetics8030069","volume":"8","author":"M Luki\u0107","year":"2021","unstructured":"Luki\u0107 M, Panteli\u0107 I, Savi\u0107 SD. Towards optimal pH of the skin and topical formulations: from the current state of the art to tailored products. Cosmetics. 2021;8(3):69. https:\/\/doi.org\/10.3390\/cosmetics8030069.","journal-title":"Cosmetics"},{"issue":"6","key":"1282_CR48","doi-asserted-by":"publisher","first-page":"2429","DOI":"10.21873\/anticanres.17614","volume":"45","author":"A Gao","year":"2025","unstructured":"Gao A, Zheng Z, Roh MR, Zhao G, Cho MY, Cho NY, et al. CA9-positive keloid fibroblasts: modulator of local inflammation induced by the hypoxic and glycolysis-enhanced microenvironment. Anticancer Res. 2025;45(6):2429\u201342. https:\/\/doi.org\/10.21873\/anticanres.17614.","journal-title":"Anticancer Res"},{"issue":"4","key":"1282_CR49","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1293\/tox.2022-0035","volume":"35","author":"Y Takai","year":"2022","unstructured":"Takai Y, Powlin S, Awasaki Y, Yamauchi T, Sano T, Takahashi H, et al. In vivo screening of subcutaneous tolerability for the development of novel excipients. J Toxicol Pathol. 2022;35(4):355\u201360. https:\/\/doi.org\/10.1293\/tox.2022-0035.","journal-title":"J Toxicol Pathol"},{"issue":"8","key":"1282_CR50","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.1002\/jps.21214","volume":"97","author":"J Tian","year":"2008","unstructured":"Tian J, Stella VJ. Degradation of paclitaxel and related compounds in aqueous solutions II: nonepimerization degradation under neutral to basic pH conditions. J Pharm Sci. 2008;97(8):3100\u20138. https:\/\/doi.org\/10.1002\/jps.21214.","journal-title":"J Pharm Sci"},{"issue":"3","key":"1282_CR51","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1021\/bi00532a007","volume":"21","author":"J Bello","year":"1982","unstructured":"Bello J, Bello HR, Granados E. Conformation and aggregation of melittin: dependence on pH and concentration. Biochemistry. 1982;21(3):461\u20135. https:\/\/doi.org\/10.1021\/bi00532a007.","journal-title":"Biochemistry"},{"issue":"4","key":"1282_CR52","doi-asserted-by":"publisher","first-page":"637","DOI":"10.3390\/toxins5040637","volume":"5","author":"T Takahashi","year":"2013","unstructured":"Takahashi T, Nomura F, Yokoyama Y, Tanaka-Takiguchi Y, Homma M, Takiguchi K. Multiple membrane interactions and versatile vesicle deformations elicited by melittin. Toxins (Basel). 2013;5(4):637\u201364. https:\/\/doi.org\/10.3390\/toxins5040637.","journal-title":"Toxins (Basel)"},{"issue":"49","key":"1282_CR53","doi-asserted-by":"publisher","first-page":"33854","DOI":"10.1074\/jbc.M805171200","volume":"283","author":"G van den Bogaart","year":"2008","unstructured":"van den Bogaart G, Guzm\u00e1n JV, Mika JT, Poolman B. On the mechanism of pore formation by melittin. J Biol Chem. 2008;283(49):33854\u20137. https:\/\/doi.org\/10.1074\/jbc.M805171200.","journal-title":"J Biol Chem"},{"issue":"9","key":"1282_CR54","doi-asserted-by":"publisher","first-page":"1570","DOI":"10.1016\/j.bbamem.2018.12.014","volume":"1861","author":"WC Wimley","year":"2019","unstructured":"Wimley WC. The mechanism of membrane permeabilization by peptides. Biochim Biophys Acta Biomembr. 2019;1861(9):1570\u201382. https:\/\/doi.org\/10.1016\/j.bbamem.2018.12.014.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"10","key":"1282_CR55","doi-asserted-by":"publisher","first-page":"2424","DOI":"10.1016\/j.bpj.2015.04.007","volume":"108","author":"JM Leveritt III","year":"2015","unstructured":"Leveritt JM III, Pino-Angeles A, Lazaridis T. The structure of a melittin-stabilized pore. Biophys J. 2015;108(10):2424\u20136. https:\/\/doi.org\/10.1016\/j.bpj.2015.04.007.","journal-title":"Biophys J"},{"key":"1282_CR56","doi-asserted-by":"publisher","first-page":"7281","DOI":"10.1038\/s41467-024-51691-1","volume":"15","author":"JP Ulmschneider","year":"2024","unstructured":"Ulmschneider JP, Thallmair S, Flack J, Ulmschneider MB. Melittin can permeabilize membranes via large transient toroidal pores. Nat Commun. 2024;15:7281. https:\/\/doi.org\/10.1038\/s41467-024-51691-1.","journal-title":"Nat Commun"},{"issue":"17","key":"1282_CR57","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.1021\/acs.jpcb.5b11705","volume":"120","author":"A Therrien","year":"2016","unstructured":"Therrien A, Fournier A, Lafleur M. Role of the cationic C-terminal segment of melittin on membrane fragmentation. J Phys Chem B. 2016;120(17):3993\u20134002. https:\/\/doi.org\/10.1021\/acs.jpcb.5b11705.","journal-title":"J Phys Chem B"},{"issue":"5","key":"1282_CR58","doi-asserted-by":"publisher","first-page":"528","DOI":"10.3892\/br.2016.639","volume":"4","author":"Z Guo","year":"2016","unstructured":"Guo Z, Peng H, Kang J, Sun D. Cell-penetrating peptides: possible transduction mechanisms and therapeutic applications. Biomed Rep. 2016;4(5):528\u201334. https:\/\/doi.org\/10.3892\/br.2016.639.","journal-title":"Biomed Rep"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01282-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-026-01282-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-026-01282-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:03:12Z","timestamp":1790665392000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-026-01282-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,8]]},"references-count":58,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["1282"],"URL":"https:\/\/doi.org\/10.1208\/s12248-026-01282-3","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,8]]},"assertion":[{"value":"21 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"133"}}